Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study

BACKGROUND: The cardiovascular safety profile of biologic therapies used for psoriasis is unclear. OBJECTIVES: To compare the risk of major cardiovascular events (CVEs; acute coronary syndrome, unstable angina, myocardial infarction and stroke) in patients with chronic plaque psoriasis treated with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Eur Acad Dermatol Venereol
Main Authors: Rungapiromnan, W., Mason, K.J., Lunt, M., McElhone, K., Burden, A.D., Rutter, M.K., Warren, R.B., Griffiths, C.E.M., Ashcroft, D.M.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Psoriasis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7155017/
https://ncbi.nlm.nih.gov/pubmed/31633837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.16018
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares